Investigation of blood mRNA biomarkers for suicidality in an independent sample

N Mullins; K Hodgson; K E Tansey; N Perroud; W Maier; O Mors; M Rietschel; J Hauser; N Henigsberg; D Souery; K Aitchison; A Farmer; P McGuffin; G Breen; R Uher; C M Lewis

doi:10.1038/tp.2014.112

Investigation of blood mRNA biomarkers for suicidality in an independent sample

N Mullins, K Hodgson, K E Tansey, N Perroud, W Maier, O Mors, M Rietschel, J Hauser, N Henigsberg, D Souery, K Aitchison, A Farmer, P McGuffin, G Breen, R Uher, C M Lewis

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

Changes in the blood expression levels of SAT1, PTEN, MAP3K3 and MARCKS genes have been reported as biomarkers of high versus low suicidality state (Le-Niculescu et al.). Here, we investigate these expression biomarkers in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study, of patients with major depressive disorder on a 12-week antidepressant treatment. Blood gene expression levels were available at baseline and week 8 for patients who experienced suicidal ideation during the study (n=20) versus those who did not (n=37). The analysis is well powered to detect the effect sizes reported in the original paper. Within either group, there was no significant change in the expression of these four genes over the course of the study, despite increasing suicidal ideation or initiation of antidepressant treatment. Comparison of the groups showed that the gene expression did not differ between patients with or without treatment-related suicidality. This independent study does not support the validity of the proposed biomarkers.

Original language	English
Article number	e474
Number of pages	4
Journal	Translational psychiatry
Volume	4
DOIs	https://doi.org/10.1038/tp.2014.112
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/tp.2014.112

Cite this

Mullins, N., Hodgson, K., Tansey, K. E., Perroud, N., Maier, W., Mors, O., Rietschel, M., Hauser, J., Henigsberg, N., Souery, D., Aitchison, K., Farmer, A., McGuffin, P., Breen, G., Uher, R., & Lewis, C. M. (2014). Investigation of blood mRNA biomarkers for suicidality in an independent sample. Translational psychiatry, 4, Article e474. https://doi.org/10.1038/tp.2014.112

@article{ac0de2b4cc3d40c5b6012fce853d9be0,

title = "Investigation of blood mRNA biomarkers for suicidality in an independent sample",

abstract = "Changes in the blood expression levels of SAT1, PTEN, MAP3K3 and MARCKS genes have been reported as biomarkers of high versus low suicidality state (Le-Niculescu et al.). Here, we investigate these expression biomarkers in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study, of patients with major depressive disorder on a 12-week antidepressant treatment. Blood gene expression levels were available at baseline and week 8 for patients who experienced suicidal ideation during the study (n=20) versus those who did not (n=37). The analysis is well powered to detect the effect sizes reported in the original paper. Within either group, there was no significant change in the expression of these four genes over the course of the study, despite increasing suicidal ideation or initiation of antidepressant treatment. Comparison of the groups showed that the gene expression did not differ between patients with or without treatment-related suicidality. This independent study does not support the validity of the proposed biomarkers.",

author = "N Mullins and K Hodgson and Tansey, {K E} and N Perroud and W Maier and O Mors and M Rietschel and J Hauser and N Henigsberg and D Souery and K Aitchison and A Farmer and P McGuffin and G Breen and R Uher and Lewis, {C M}",

year = "2014",

doi = "10.1038/tp.2014.112",

language = "English",

volume = "4",

journal = "Translational psychiatry",

issn = "2158-3188",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Investigation of blood mRNA biomarkers for suicidality in an independent sample

AU - Mullins, N

AU - Hodgson, K

AU - Tansey, K E

AU - Perroud, N

AU - Maier, W

AU - Mors, O

AU - Rietschel, M

AU - Hauser, J

AU - Henigsberg, N

AU - Souery, D

AU - Aitchison, K

AU - Farmer, A

AU - McGuffin, P

AU - Breen, G

AU - Uher, R

AU - Lewis, C M

PY - 2014

Y1 - 2014

N2 - Changes in the blood expression levels of SAT1, PTEN, MAP3K3 and MARCKS genes have been reported as biomarkers of high versus low suicidality state (Le-Niculescu et al.). Here, we investigate these expression biomarkers in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study, of patients with major depressive disorder on a 12-week antidepressant treatment. Blood gene expression levels were available at baseline and week 8 for patients who experienced suicidal ideation during the study (n=20) versus those who did not (n=37). The analysis is well powered to detect the effect sizes reported in the original paper. Within either group, there was no significant change in the expression of these four genes over the course of the study, despite increasing suicidal ideation or initiation of antidepressant treatment. Comparison of the groups showed that the gene expression did not differ between patients with or without treatment-related suicidality. This independent study does not support the validity of the proposed biomarkers.

AB - Changes in the blood expression levels of SAT1, PTEN, MAP3K3 and MARCKS genes have been reported as biomarkers of high versus low suicidality state (Le-Niculescu et al.). Here, we investigate these expression biomarkers in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study, of patients with major depressive disorder on a 12-week antidepressant treatment. Blood gene expression levels were available at baseline and week 8 for patients who experienced suicidal ideation during the study (n=20) versus those who did not (n=37). The analysis is well powered to detect the effect sizes reported in the original paper. Within either group, there was no significant change in the expression of these four genes over the course of the study, despite increasing suicidal ideation or initiation of antidepressant treatment. Comparison of the groups showed that the gene expression did not differ between patients with or without treatment-related suicidality. This independent study does not support the validity of the proposed biomarkers.

U2 - 10.1038/tp.2014.112

DO - 10.1038/tp.2014.112

M3 - Article

C2 - 25350297

SN - 2158-3188

VL - 4

JO - Translational psychiatry

JF - Translational psychiatry

M1 - e474

ER -

Investigation of blood mRNA biomarkers for suicidality in an independent sample

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this